Tagged drug-discovery
Press Release
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
Maryland-based biotechnology leader, Elixirgen Scientific, Inc., launches Alzheimer’s Disease Panel, strengthening their commitment to quality and innovation in disease research and drug discovery. Read More
Press Release
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
Next-generation proteomics technology made available to the biotech and pharmaceutical industry through the acquisition of Methuselah Health by leading R&D services provider, RxCelerate Read More
Press Release
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit
At the Annual Summit, Dr. Andrea Small-Howard is presenting a Keynote Address that includes data from case studies demonstrating the utility of Gb Sciences' proprietary PhAROS drug discovery platform. Read More
Press Release
ReachBio and abc biopply Partner to Intensify Support for De-Risking Pharma's Drug Development Process
Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their clients with an even more predictive assay portfolio to further increase the efficiency of their drug discovery and development process. Read More
Press Release
PharmaNest Announces New Pre-Clinical and Clinical NASH Data to Be Presented at the AASLD - The Liver Meeting Digital Experience™ (TLMdX) 2021
New digital pathology, quantitative image analysis and quantitative AI method for liver tissues is presented for the continuous assessment of the histological phenotype(s) of fibrosis, including severity and regression of fibrosis in Human in-vitro 3D NASH Spheroid models, NASH rodent models, Clinical Phase2b NASH Studies at the Liver Meeting Digital Experience™ 2021 Read More
Press Release
BenchSci Expands Board of Directors With Appointment of Life Sciences, Tech, and Healthcare Leader Luba Greenwood
Industry veteran will provide strategic guidance to company as it pursues its vision of using machine learning to bring novel medicine to patients 50% faster by 2025 Read More
Press Release
BenchSci Signifies Growth of Machine Learning Product Portfolio With Appointment of Chief Platform Officer
Experienced product and engineering leader Eran Ben-Ari joins BenchSci to scale the creation of a sophisticated machine learning-based product portfolio that's transforming life-saving R&D Read More
Press Release
Three Senior Pharma R&D Leaders Join BenchSci's Science Advisory Board
Steve Hitchcock, Philip Larsen, and Philip Tagari named science advisors, providing BenchSci with global industry expertise to realize its vision of using machine learning to bring novel medicine to patients 50% faster by 2025 Read More
Press Release
3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery
3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials - and to maximize their chances of success. Read More
Press Release
5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021
There is free registration for all interested attendees: http://tinyurl.com/SDDS2021. Co-Sponsored by the Stanford Cardiovascular Institute, Stanford Cancer Institute, Stanford Cardiovascular Health, and many others. Read More
Press Release
BenchSci Expands Scientists' Access to Critical Experimental Insights With Addition of Top Journals From Taylor & Francis
Agreement will enhance BenchSci's vast biomedical database to help scientists run more successful experiments while increasing discoverability of Taylor & Francis Group research Read More
Press Release
Precision Medicine Market to register over 11% CAGR through 2026: Global Market Insights, Inc.
Some of the major precision Medicine market players are Tepnel Pharma Services, Biocrates Life Sciences, Qiagen, Novartis, NanoString Technologies, Menarini Silicon Biosystems, Pfizer, Eagle Genomics, Roche, Intomics, Quest Diagnostics, and Teva Pharmaceutical. Read More
Press Release
